Voxelotor: increased hemoglobin, reduced hemolysis markers in sickle cell disease

Voxelotor increased hemoglobin levels and reduced markers of hemolysis compared to placebo in patients with sickle cell disease, according to…

Read More

Discover the next-generation of MRD assessment

Discover the next-generation of MRD assessment. Gain insights into the science of molecular testing and its potential

Read More

Clinical Utilization of MRD in Multiple Myeloma: an in-depth view

The aim of this programme is to improve knowledge of the measurement, clinical application and interpretation of MRD in MM

Read More

ALAN leads the first global HRQoL survey in acute leukemia

Filling the information void: acute leukemia quality of life data is lacking and ALAN is calling for your support!

Read More

ERIC 2018
E-learning

Watch webcast presentations from the ERIC 2018 International Meeting now!

Read More

Addressing the challenges in multiple myeloma

Advances continue to be made in the diagnosis and treatment of multiple myeloma, leading to improved patient care and outcomes….

Read More

Mohamad and Saad’s ASH takeaway

The definitive guide to multiple myeloma at ASH 2018

Read More

Myeloma2018
E-learning

Explore the latest updates from Myeloma2018 with new e-learning webcasts available now!

Read More
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals